Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation

Reem Karmali, MD, Jeremy S. Abramson, MD MMSc, Deborah M. Stephens, DO, Jeffrey A. Barnes, MD PhD, Jason Kaplan, MD, Jane N. Winter, MD, Shuo Ma, MD PhD, Juehua Gao, MD PhD, Adam M. Petrich, MD, Ephraim Hochberg, MD, Ronald W. Takvorian, MD, Frank Kuhr, PhD, Valerie Nelson, MD MBA, Leo I. Gordon, MD, Barbara Pro, MD

Blood (2019) 134 (Supplement_1): 3990.

https://doi.org/10.1182/blood-2019-126920

Published: 2019

Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival

Cristiana A Costa, DO, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd A MacKenzie, PhD, Anne W Beaven, MD, Frederick Lansigan, MD

Blood (2016) 128 (22): 1793.

https://doi.org/10.1182/blood.V128.22.1793.1793

Published: 2016

Journal Articles

Incidence of Malignancies in Gaucher's Disease Patients. Data of Spanish Gaucher's Disease Registry

Marcio Andrade-Campos, MD PhD, Abelardo Barez, Soledad Noya, M Angeles Fernández-Galán, Jose Balanzat, MD, F García-Bragado, Angela Ibañez, Pilar Giraldo, MD PhD

Blood (2016) 128 (22): 4881.

https://doi.org/10.1182/blood.V128.22.4881.4881

Published: 2016

Journal Articles

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

Mai Aly, Naoko Hosono, MD,PhD, Przychodzen Bartlomiej, Hideki Makishima, MD PhD FACP., Nagata Yasunobu, MDPhD, Cassandra M. Hirsch, BSc, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2016) 128 (22): 3156.

https://doi.org/10.1182/blood.V128.22.3156.3156

Published: 2016

Journal Articles

Categorizing Molecular Mutations in MDS and AML

Dominic Rose, PhD, Torsten Haferlach, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2015) 126 (23): 5222.

https://doi.org/10.1182/blood.V126.23.5222.5222

Published: 2015

Journal Articles

Effects of the Timing of Venous Thromboembolic Events on Survival of Patients with Uterine Cancer

Heera Remasankar, MD, Xiao Zhou, MD PhD, Saroj Vadhan-Raj, MD

Blood (2014) 124 (21): 1534.

https://doi.org/10.1182/blood.V124.21.1534.1534

Published: 2014

Journal Articles

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Yosra Aljawai, MS, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, MS, Steven Peter Treon, MD, MA, PhD, Edie A. Weller, PhD, Brenda M. Birmann, ScD, Irene M Ghobrial, MD

Blood (2013) 122 (21): 1713.

https://doi.org/10.1182/blood.V122.21.1713.1713

Published: 2013

Journal Articles

BARD1: a New Target In Leukemia

Francesco Paolo Tambaro, MD, PhD, Ilaria Lepore, Carmela Dell Aversana, Floriana De Bellis, Marco Miceli, Vincenzo Carafa, Angela Nebbioso, Felicetto Ferrara, MD, Guillermo garcia Manero, MD, Lucia Altucci

Blood (2010) 116 (21): 4642.

https://doi.org/10.1182/blood.V116.21.4642.4642

Published: 2010

Journal Articles

Phase II Study of Short Course CHOP-Rituximab Followed by 90-Y Ibritumomab Tiuxetan as First-Line Treatment for Follicular Lymphoma: An Update and Extension of Preliminary Findings on Predictors of Relapse.

Rachel C. Jankowitz, MD, Kenneth A. Foon, MD, The Minh Luong, M.Sc, Stephanie R. Land, PhD, Nicholas A. DeMonaco, MD, Steven H. Swerdlow, MD, Judith Joyce, MD, Jennifer Osborn, MD, Terry Evans, MD, Samuel A. Jacobs, MD

Blood (2008) 112 (11): 2001.

https://doi.org/10.1182/blood.V112.11.2001.2001

Published: 2008

Journal Articles

Analysis of Expanded Human Cytokine Induced Killer Cells for Cellular Therapy.

Jeanette Baker, Kevin Sheehan, Gina Monterola, Nancy Staines, Robert S. Negrin

Blood (2005) 106 (11): 1063.

https://doi.org/10.1182/blood.V106.11.1063.1063

Published: 2005

Journal Articles

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Loretta S. Li, BS, Dezheng Huo, MS, Theodore Karrison, PhD, Richard A. Larson, MD, Olufunmilayo Olopade, MD

Blood (2004) 104 (11): 2018.

https://doi.org/10.1182/blood.V104.11.2018.2018

Published: 2004

NARROW

Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival

Incidence of Malignancies in Gaucher's Disease Patients. Data of Spanish Gaucher's Disease Registry

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

Categorizing Molecular Mutations in MDS and AML

Effects of the Timing of Venous Thromboembolic Events on Survival of Patients with Uterine Cancer

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

BARD1: a New Target In Leukemia

Phase II Study of Short Course CHOP-Rituximab Followed by 90-Y Ibritumomab Tiuxetan as First-Line Treatment for Follicular Lymphoma: An Update and Extension of Preliminary Findings on Predictors of Relapse.

Analysis of Expanded Human Cytokine Induced Killer Cells for Cellular Therapy.

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only